Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
8
×
fda
8
×
life sciences
national blog main
clinical trials
san francisco blog main
national top stories
san diego blog main
san diego top stories
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
ipo
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston
cancer
investing
medical devices
national
biofourmis
black diamond therapeutics
chronic kidney disease
chronic rhinosinusitis
crispr
deals
What
therapeutics
8
×
ipo
million
new
raised
companies
drug
treat
bio
biotech
black
cancer
company
debut
developing
diamond
immunotherapy
late
leading
life
medicines
public
roundup
science
week
agency
aimmune
allergy
allogene
analytics
approval
approved
awarded
biofourmis
biotechs
brings
clinic
club
continue
continued
Language
unset
Current search:
fda
×
therapeutics
×
" boston top stories "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M